These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8549349)

  • 61. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics and tolerability of prulifloxacin after single oral administration.
    Picollo R; Brion N; Gualano V; Millérioux L; Marchetti M; Rosignoli MT; Dionisio P
    Arzneimittelforschung; 2003; 53(3):201-5. PubMed ID: 12705176
    [TBL] [Abstract][Full Text] [Related]  

  • 63. New quinolones--in vivo antibacterial activity.
    Goto S; Miyazaki S
    Prog Drug Res; 1992; 38():29-37. PubMed ID: 1609116
    [No Abstract]   [Full Text] [Related]  

  • 64. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prophylactic antibiotics in renal transplantation.
    Melchor JL; Gracida C
    Transplant Proc; 1996 Dec; 28(6):3305. PubMed ID: 8962283
    [No Abstract]   [Full Text] [Related]  

  • 66. New antibiotic approved for community-acquired infections.
    Nurse Pract; 1998 Jan; 23(1):94. PubMed ID: 9470200
    [No Abstract]   [Full Text] [Related]  

  • 67. In vitro and in vivo antibacterial activities of AM-1155 in the fields of obstetrics and gynecology.
    Mikamo H; Kawazoe K; Sato Y; Hayasaki Y; Izumi K; Tamaya T
    Chemotherapy; 1998; 44(4):238-42. PubMed ID: 9681200
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of 6-fluoro-8-methoxy quinolone (AM-1155) against chronic airway infection with Pseudomonas aeruginosa in a rat model.
    Sato A; Kitazawa H; Hayakawa H; Chida K; Iwata M
    J Antimicrob Chemother; 1997 Feb; 39(2):217-22. PubMed ID: 9069542
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunomodulating activity of DW-116, a new quinolone antibiotic.
    Moon EY; Choi CH; Pyo S; Chung YH; Yoon SJ; Lee DK
    Arch Pharm Res; 1998 Oct; 21(5):610-4. PubMed ID: 9875503
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Fluoroquinolones: importance, development of research, new drugs, questions for discussion].
    Padeĭskaia EN
    Antibiot Khimioter; 1998; 43(11):38-44. PubMed ID: 10079866
    [No Abstract]   [Full Text] [Related]  

  • 71. Pharmacokinetic and clinical studies of T-3761 in otorhinolaryngeal infections.
    Shinkawa A; Kimura H; Sakai M; Miyake H
    Drugs; 1995; 49 Suppl 2():401-2. PubMed ID: 8549377
    [No Abstract]   [Full Text] [Related]  

  • 72. Comparison of the pharmacodynamic properties of quinolones.
    Wiedemann B; Rustige-Wiedemann C; Kratz B
    Drugs; 1995; 49 Suppl 2():269-71. PubMed ID: 8549328
    [No Abstract]   [Full Text] [Related]  

  • 73. Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin.
    Nord CE
    Infection; 1999; 27(3):166-72. PubMed ID: 10378126
    [No Abstract]   [Full Text] [Related]  

  • 74. Effects of antacid on absorption and excretion of new quinolones.
    Shiba K; Sakamoto M; Nakazawa Y; Sakai O
    Drugs; 1995; 49 Suppl 2():360-1. PubMed ID: 8549362
    [No Abstract]   [Full Text] [Related]  

  • 75. Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
    Uno T; Okuno T; Kawakami K; Sakamoto F; Tsukamoto G
    J Med Chem; 1993 Sep; 36(19):2711-5. PubMed ID: 8410985
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Release of pefloxacin bonded on catheters after intraperitoneal implantation in mice.
    Carsenti-Etesse H; Forget B; Bensoussan M; Bensoussan F; Dellamonica P
    Drugs; 1995; 49 Suppl 2():304-6. PubMed ID: 8549342
    [No Abstract]   [Full Text] [Related]  

  • 77. Quinolone prophylaxis during neutropenia.
    Chandrasekar PH
    Ann Intern Med; 1991 Nov; 115(10):833. PubMed ID: 1929033
    [No Abstract]   [Full Text] [Related]  

  • 78. Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines.
    Blagburn BL; Sundermann CA; Lindsay DS; Hall JE; Tidwell RR
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1520-3. PubMed ID: 1929322
    [TBL] [Abstract][Full Text] [Related]  

  • 79. European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacin.
    Phillips I; Acar J; Baquero F; Bergan T; Degener J; Forsgren A; Schito GC; Wiedemann B
    Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):283-4. PubMed ID: 8050449
    [No Abstract]   [Full Text] [Related]  

  • 80. Unique aspects of quinolone pharmacokinetics.
    Lode H; Höffken G; Borner K; Koeppe P
    Clin Pharmacokinet; 1989; 16 Suppl 1():1-4. PubMed ID: 2653691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.